Search

everythinglearnresearchcommunity

for

Search:↓

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

AR gene variations don't affect aging markers in men.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Excess androgens may cause PCOS, not just be a symptom.